Among them, high PRMT8 expression was associated with increased patient survival in patients suffering from breast and ovarian cancer, while the opposite was true in gastric cancer, where high PRMT8 expression was associated with decreased patient survival [103]. The gene discussed is PRMT8; the disease is ovarian cancer.